Saturday, July 11, 2026

pharma · Pancreatic Cancer Non-resectable

Shanghai Proton and

Shanghai Proton and is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pancreatic Cancer Non-resectable. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent reco

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
2
Patents
0
Clinical program

Carbon ion radiotherapy

Unknown · other · Pancreatic Cancer Non-resectable

Carbon ion radiotherapy for Pancreatic Cancer Non-resectable is a Unknown program (other) at Shanghai Proton and Heavy Ion Center with 1 ClinicalTrials.gov record(s).

Internal code SPHIC-TR-PaCa2022-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Shanghai Proton and Heavy Ion Center
Phase
Unknown
Modality
other
Indication
Pancreatic Cancer Non-resectable
Status
active
Trials
1